Skip to main content

Role of Neuropeptides in the Bidirectional Communication Between the Immune and Neuroendocrine Systems

  • Chapter
Neuropeptides and Immunoregulation

Abstract

Vertebrates respond to infection and inflammation with a complex series of intercellular communication signals involving the immune, nervous, and endocrine systems. Recent investigations have shown that the immune system is subject to neural and endocrine control, and that it exerts in turn a reciprocal effect on the nervous system. In addition, the immune system is capable of producing neuropeptides, and the nervous system is able to secrete cytokines. This chapter summarizes the evidence for the production and function of neuropeptides in this regulatory relationship. The neuropeptides discussed here include corticotropin (ACTH), β-endorphin, vasoactive intestinal peptide (VIP), somatostatin (SOM), and substance P. Overall, a rapidly expanding body of evidence indicates that neuropeptides and cytokines are the common signal molecules that mediate bidirectional communication between the immune and neuroendocrine systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alvarez-Mon A, Kehrl JH, Fauci AS (1985) A potential role for adrenocorticotropin in regulating human B-lymphocyte functions. J Immunol 135: 3823–3826

    PubMed  CAS  Google Scholar 

  • Antoni FA (1986) Hypothalamic control of ACTH secretion. Endocr Rec 2: 351–378

    Article  Google Scholar 

  • Bar-Shavit Z, Goldman R, Stabinsky Y, Gottleib F, Fridkin M, Teichberg V, Blumberg S (1980) Enhancement of phagocytosis— a newly found activity of substance P residing in its N- terminal tetrapeptide sequence. Biochem Biophys Res Commun 94: 1445–1451

    Article  PubMed  CAS  Google Scholar 

  • Bellinger DL, Lorton D, Romano TD, Olschowka JA, Felten SY, Felten DL (1990) Neuropeptide innervation of lymphoid organs. Ann NY Acad Sci 594: 17–33

    Article  PubMed  CAS  Google Scholar 

  • Bessler H, Sztein MB, Serrate SA (1990) ß-Endorphin modulation of IL-1 induced IL-2 production. Immunopharmacology 19: 5–14

    Article  PubMed  CAS  Google Scholar 

  • Bhathena SJ, Louie J, Schechter GP, Redman RS, Wahl L, Recant L (1981) Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes 30: 127–131

    Article  PubMed  CAS  Google Scholar 

  • Blalock JE (1984) The immune system as a sensory organ. J Immunol 132: 1067–1070

    PubMed  CAS  Google Scholar 

  • Blalock JE, Smith EM (1980) Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci USA 77: 5972–5974

    Article  PubMed  CAS  Google Scholar 

  • Bost KL, Blalock JE (1985) Molecular characterization of a corticotropin ( ACTH) receptor. Mol Cell Endocrinol 44: 1–9

    Google Scholar 

  • Bozzola M, Moretta A, Maccario R, Bohen M, Burgio GR (1987) Modulating effect of growth hormone (GH) on in vitro lymphoproliferation. 1st European congress on endocrinology, Copenhagen, abstract no 148

    Google Scholar 

  • Brown SL, Van Epps D (1986) Opioid peptides modulate production of interferon-y by human mononuclear cells. Cell Immunol 103: 19–26

    Article  PubMed  CAS  Google Scholar 

  • Buzzetti R, McLoughlin L, Lavender PM, Clark AJL, Rees LH (1989) Expression of proopiomelanocortin gene and quantification of adrenocorticotropic hormone-like immuno-reactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 83: 733–737

    Article  PubMed  CAS  Google Scholar 

  • Carr DJJ, Klimpel GR (1986) Enhancement of the generation of cytotoxic T-cells by endogenous opiates. J Neuroimmunol 12: 75–87

    Article  PubMed  CAS  Google Scholar 

  • Carr DJJ, DeCosta BR, Jacobson AE, Rice KC, Blalock JE (1990) Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway. J Neuroimmunol 28: 53–61

    Article  PubMed  CAS  Google Scholar 

  • Ferreira JA, Carstens ME, Taljaard JJF (1990) Quantitative determination of lymphocyte ACTH-1–39. Neuropeptides 15: 11–15

    Article  PubMed  CAS  Google Scholar 

  • Foris G, Medgyesi GA, Gyimesi E, Hauck M (1984) Met-enkephalin induced alterations of macrophage functions. Mol Immunol 21: 747–750

    Article  PubMed  CAS  Google Scholar 

  • Froelich OJ, Bankhurst AD (1984) The effect of beta-endorphin on natural cytotoxicity and antibody-dependent cellular cytotoxicity. Life Sci 35: 261–265

    Article  PubMed  CAS  Google Scholar 

  • Fuller PJ, Verity K (1989) Somatostatin gene expression in the thymus gland. J Immunol 143: 1015–1017

    PubMed  CAS  Google Scholar 

  • Galin FS, LeBoeuf RD, Blalock JE (1991) Corticotropin releasing factor unregulates expression of two truncated pro-opiomelanocortin transcripts in lymphocytes. J Neuroimmunol 31: 51–58

    Article  PubMed  CAS  Google Scholar 

  • Gibbons JM, Mitnick M, Chieffo V (1975) In vitro biosynthesis of TSH and LH-releasing factors by the human placenta. Am J Obstet Gynecol 121: 127–131

    PubMed  CAS  Google Scholar 

  • Gilman SC, Schwartz JM, Milner RJ, Bloom FE, Feldman JD (1982) ß-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA 79: 4226–4230

    Article  PubMed  CAS  Google Scholar 

  • Goetzl EJ, Payan DG (1984) Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol 133: 3255–3259

    PubMed  CAS  Google Scholar 

  • Goetzl EJ, Chernov T, Renold F, Payan DG (1985) Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135: 8025–8055

    Google Scholar 

  • Goetzl EJ, Sreedharan SP, Turck DW (1988) Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells. J Biol Chem 263: 9083–9086

    PubMed  CAS  Google Scholar 

  • Goetzl EJ, Grotmol T, Van Dyke RW, Turck CW, Wershil B, Galli Si, Sreedharan SP (1990a) Generation and recognition of vasoactive intestinal peptide by cells of the immune system. Ann NY Acad Sci 594: 34–44

    Article  PubMed  CAS  Google Scholar 

  • Goetzl EJ, Adelman DC, Sreedharan SP (1990b) Neuroimmunology. In: Dixon FJ, Austen KF, Hood L, Uhr UW (eds) Advances in immunology. Academic Press, New York

    Google Scholar 

  • Goetzl EJ, Turck C, Sreedharan S (1991) Production and recognition of neuropeptides by cells of the immune system. In: Ader R, Cohen N, Felten DL (eds) Psychoneuroimmunology, 2nd edn. Academic, New York, pp 263–282

    Google Scholar 

  • Guerrero JM, Prieto JC, Elorza FL, Ramirez R, Goberna R (1981) Interaction of vasoactive intestinal peptide with human blood mononuclear cells. Mol Cell Endocrinol 21: 151–160

    Article  PubMed  CAS  Google Scholar 

  • Hadjupetrou-Kourounakis L, Karagounis E, Rekka E, Kourounakis P (1989) Immunosuppression by a novel opioid agonist. Scand J Immunol 29: 449–458

    Article  Google Scholar 

  • Harbour DV, Smith EM, Blalock JE (1987) A novel processing pathway for proopiomelanocortin in lymphocytes: endotoxin induction of a new prohormone-cleaving enzyme. J Neurosci Res 18: 95–101

    Article  PubMed  CAS  Google Scholar 

  • Harbour-McMenamin DV, Smith EM, Blalock JE (1985) Endotoxin induction of leukocyte-derived proopiomelanocortin related peptides. Infect Immun 48: 813–819

    PubMed  CAS  Google Scholar 

  • Hargreaves KM, Costello AH, Joris JL (1987) Release from inflamed tissue of a substance with properties similar to corticotropin-releasing factor. Neuroendocrinology 49: 476–482

    Article  Google Scholar 

  • Healy DL, Hodgen GD, Schulte HM, Chrousos GP, Loriaux DL, Hall NR, Goldstein AL (1983) The thymus adrenal connection: thymosin has corticotropin releasing activity in primates. Science 222: 1353–1355

    Article  PubMed  CAS  Google Scholar 

  • Heijnen CJ, Bevers C, Kavelaars A, Ballieux RE (1986) Effect of a-endorphin on the antigen-induced primary antibody response of human blood B-cells in vitro. J Immunol 136: 213–216

    PubMed  CAS  Google Scholar 

  • Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C (1986) Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporin. Proc Natl Acad Sci USA 83: 2599–2603

    Article  PubMed  CAS  Google Scholar 

  • Johnson HM, Torres BA (1985) Regulation of lymphokine production by arginine vasopressin and oxytocin: modulation of lymphocyte function by neurohypophyseal hormones. J Immunol 135: 773s - 775s

    PubMed  CAS  Google Scholar 

  • Johnson HM, Smith EM, Torres BA, Blalock JE (1982) Neuroendocrine hormone regulation of in vitro antibody production. Proc Natl Acad Sci USA 79: 4171–4174

    Article  PubMed  CAS  Google Scholar 

  • Johnson HM, Torres BA, Smith EM, Dion LD, Blalock JE (1984) Regulation of lymphokine (interferon-y) production by corticotropin. J Immunol 132: 246–250

    PubMed  CAS  Google Scholar 

  • Kavelaars A, Ballieux RE, Heijnen CJ (1989) The role of IL-1 in the corticotropin-releasing factor and arginine vasopressin-induced secretion of immunoreactive ß-endorphin by human peripheral blood mononuclear cells. J Immunol 142: 2338–2342

    PubMed  CAS  Google Scholar 

  • Kavelaars A, Ballieux RE, Heijnen CJ (1990a) ß-Endorphin secretion by human peripheral blood mononuclear cells: regulation by glucocorticoids. Life Sci 46: 1233–1240

    Article  PubMed  CAS  Google Scholar 

  • Kavelaars A, Berkenbosch F, Croiset G, Ballieux RE, Heijnen CJ (1990b) Induction of ß-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 126: 759–764

    Article  PubMed  CAS  Google Scholar 

  • Khodr GS, Siler-Khodr TM (1980) Placental luteinizing hormone-releasing factor and its synthesis. Science 207: 315–317

    Article  PubMed  CAS  Google Scholar 

  • Koff WC, Dunegan MA (1985) Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol 135: 350–354

    PubMed  CAS  Google Scholar 

  • Kruger TE, Smith LR, Harbour DV, Blalock JE (1989) Thyrotropin: an endogenous regulator of the in vitro immune response. J Immunol 142: 744–747

    PubMed  CAS  Google Scholar 

  • Lolait SJ, Lim ATW, Toh BH, Funder JW (1984) Immunoreactive ß-endorphin in a subpopulation of mouse spleen macrophages. J Clin Invest 73: 277–280

    Article  PubMed  CAS  Google Scholar 

  • Liolait SJ, Clements JA, Markwick AJ, Cheng C, McNally M, Smith AI, Funder JW (1986) Proopiomelanocortin messenger ribonucleic acid and posttranslational processing of ß-endorphin in spleen macrophages. J Clin Invest 77: 1776–1779

    Article  Google Scholar 

  • Lundbert JM, Saria A, Brodin E, Rossell S, Folkars K (1983) A substance P antagonist inhibits vagally-induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci USA 80: 1120–1124

    Article  Google Scholar 

  • Lygren I, Revhaug A, Burhol PG, Giercksky KE, Jenssen TG (1984) Vasoactive intestinal polypeptide and somatostatin in leucocytes. Scand J Clin Lab Invest 44: 347–351

    Article  PubMed  CAS  Google Scholar 

  • Marchetti B, Guarcello V, Morale MC, Bartoloni G, Farinella Z, Cordaro S, Scapagnini U (1989) Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function. Endocrinology 125: 1025–1036

    Article  PubMed  CAS  Google Scholar 

  • Marchetti B, Maier CC, LeBoeuf RD, Blalock JE (1990) Luteinizing hormone-releasing hormone gene expression in the thymus. Annual meeting of the society for Neuroscience, 28 Oct-2 Nov, 1990, St Louis, Missouri

    Google Scholar 

  • Mathews PM, Froelich CJ, Sibbitt WL, Bankhurst AD (1983) Enhancement of natural cytotoxicity by ß-endorphin. J Immunol 130: 1658–1662

    PubMed  CAS  Google Scholar 

  • Mcllhinney RAJ, Schulster D (1975) Studies on the binding of 125I-labelled corticotropin to isolated rat adrenocortical cells. J Endocrinol 64: 175–184

    Article  Google Scholar 

  • Merrill JE, Kutsunai S, Mohlstrom C, Hofman F, Groopman J, Golde DW (1984) Proliferation of astroglia and oligodendroglia in response to human T-cell-derived factors. Science 224: 1428–1430

    Article  PubMed  CAS  Google Scholar 

  • Moore TC (1984) Modification of lymphocyte traffic by vasoactive neurotransmitter substance. Immunology 52: 511–518

    PubMed  CAS  Google Scholar 

  • Oates EL, Allaway GP, Armstrong GR, Boyajian RA, Kehrl JH, Prabhakar BS (1988) Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. J Biol Chem 263: 10041–10044

    Google Scholar 

  • Oleson DR, Johnson DR (1988) Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists. Brain Behav Immun 2: 171–186

    Article  PubMed  CAS  Google Scholar 

  • Ottaway CA (1984) In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T-cells. J Exp Med 160: 1054–1069

    Article  PubMed  CAS  Google Scholar 

  • Ottaway CA, Greenberg GR (1984) Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J Immunol 132: 417–423

    PubMed  CAS  Google Scholar 

  • Pawlikowski M, Stepien H, Kunert-Radek J, Schally AV (1985) Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro. Biochem Biophys Res Commun 129: 52–55

    Article  PubMed  CAS  Google Scholar 

  • Pawlikowski M, Zelazowski P, Dohler KD, Stepien H (1988) Effects of two neuropeptides: Somatoliberin (GHRH) and corticoliberin ( CRF) on human lymphocyte natural killer activity. Brain Behav Immun 2: 50–56

    Google Scholar 

  • Payan DG, Brewster DR, Goetzl EJ (1983) Specific stimulation of human T-lymphocytes by substance P. J Immunol 131: 1613–1615

    PubMed  CAS  Google Scholar 

  • Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ (1984a) Substance P recognition by a subset of human T-lymphocytes. J Clin Invest 74: 1532–1539

    Article  PubMed  CAS  Google Scholar 

  • Payan DG, Hess CA, Goetzl EJ (1984b) Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol 84: 433–438

    Article  PubMed  CAS  Google Scholar 

  • Payan DG, Levine JD, Goetzl EJ (1984c) Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 132: 1601–1604

    PubMed  CAS  Google Scholar 

  • Piotrowski W, Mead M, Foreman JC (1987) Action of the SP2–11 and SP3–11 fragments of substance P on rat peritoneal mast T-cells. Agents Actions 20: 178–180

    Article  PubMed  CAS  Google Scholar 

  • Rivier CL, Plotsky PM (1986) Mediation by corticotropin-releasing factor of adenohypophysial hormone secretion. Annu Rev Physiol 48: 475–494

    Article  PubMed  CAS  Google Scholar 

  • Rola-Pleszczynski M, Bulduc D, St Pierre A (1985) The effects of VIP on human NK cell function. J Immunol 135: 2659–2673

    Google Scholar 

  • Ruff MR, Wahl SM, Pert CB (1985) Substance P receptor-mediated chemotaxis of human monocytes. Peptides 6: 107–111

    Article  PubMed  CAS  Google Scholar 

  • Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, Go M, Shimizu Y, Hanew K, Yoshinaga K (1987) Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery. J Clin Endocrinol Metab 64: 224–229

    Article  PubMed  CAS  Google Scholar 

  • Sasaki A, Shuichi S, Shigeru Y, Hanew K, Miru Y, Yoshinaga K (1989) Multiple forms of immunoreactive growth hormone-releasing hormone in human plasma, hypothalamus, and tumor tissues. J Clin Endocrinol Metab 68: 180–185

    Article  PubMed  CAS  Google Scholar 

  • Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D (1985) Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 135: 1331–1337

    PubMed  CAS  Google Scholar 

  • Shibasaki.T, Odagiri E, Shizume K, Rainey N (1982) Corticotropin-releasing factor-like activity in human placental extracts. J Clin Endocrinol Metab 55: 384–386

    Article  Google Scholar 

  • Shibasaki T, Kiyosawa Y, Masuda A, Nakahara M, Imaki T, Wakabayashi I, Demura H, Shizume K, Ling N (1984) Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts. J Clin Endocrinol Metab 59: 263–268

    Article  PubMed  CAS  Google Scholar 

  • Singh VK (1989) Stimulatory effect of corticotropin releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J Neuroimmunol 23: 257–262

    Article  PubMed  CAS  Google Scholar 

  • Smith EM, Blalock JE (1981) Human lymphocyte production of ACTH and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci USA 78: 7530–7534

    Article  PubMed  CAS  Google Scholar 

  • Smith EM, Meyer WJ, Blalock JE (1982) Virus induced increases in corticosterone in hypophysectomy mice: a possible lymphoid-adrenal axis. Science 218: 1311–1313

    Article  PubMed  CAS  Google Scholar 

  • Smith EM, Phan M, Coppenhaver D, Kruger TE, Blalock JE (1983) Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci USA 80: 6010–6013

    Article  PubMed  CAS  Google Scholar 

  • Smith EM, Morrill AC, Meyer,WJ, Blalock JE (1986) Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 322: 881–882

    Google Scholar 

  • Smith EM, Galin FS, LeBoeuf RD, Copenhaver DH, Harbour DV, Blalock JE (1990) Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of truncated peptide. Proc Natl Acad Sci USA 87: 1057–1060

    Article  PubMed  CAS  Google Scholar 

  • Stanisz AM, Befus D, Bienenstock J (1986) Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer’s patches, mesenteric lymph nodes, and spleen. J Immunol 136: 152–156

    PubMed  CAS  Google Scholar 

  • Stanisz AM, Scicchitano R, Payan DG, Bienenstock J (1987a) In vitro studies of immunoregulation of substance P and somatostatin. Ann NY Acad Sci 496: 217–225

    Article  PubMed  CAS  Google Scholar 

  • Stanisz AM, Scicchitano R, Dazin P, Bienenstock J, Payan DG (1987b) Distribution of substance P receptors on murine spleen and Peyer’s patch T- and B-cells. J Immunol 139: 749–754

    PubMed  CAS  Google Scholar 

  • Stephanou A, Jessop DS, Knight RA, Lightman SL (1990) Corticotropin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 4: 67–73

    Article  PubMed  CAS  Google Scholar 

  • Theoharides TC, Douglas WW (1981) Mast cell histamine secretion in response to somatostatin analogues: structural considerations. Eur J Pharmacol 73: 131–136

    Article  PubMed  CAS  Google Scholar 

  • Van Epps D, Saland L (1984) ß-Endorphin and Met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol 132: 3046–3053

    PubMed  Google Scholar 

  • Weigent DA, Blalock JE (1987) Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev 100: 79–108

    Article  PubMed  CAS  Google Scholar 

  • Weigent DA, Blalock JE (1990) Immunoreactive growth hormone-releasing hormone in rat leukocytes. J Neuroimmunol 29: 1–13

    Article  PubMed  CAS  Google Scholar 

  • Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE (1988) Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 2: 2812–2818

    PubMed  CAS  Google Scholar 

  • Weinstock JV, Blum AM (1990) Release of substance P by granuloma eosinophils in response to secretagogues in murine Schistosomiasis mansoni. Cell Immunol 125: 380–385

    Article  PubMed  CAS  Google Scholar 

  • Wenger GD, O’Dorisio MS (1990) Vasoactive intestinal peptide: messenger in a neuroimmune axis. Ann NY Acad Sci 594: 104–119

    Article  PubMed  CAS  Google Scholar 

  • Westley HJ, Kleiss AJ, Kelley KW, Wong PKY, Yuen P-H (1986) Newcastle’s disease virus-infected splenocytes express the pro-opiomelanocortin gene. J Exp Med 163: 1589–1594

    Article  Google Scholar 

  • Woloski BMRNJ, Smith EM, Meyer WJ III, Fuller GM, Blalock JE (1985) Corticotropinreleasing activity of monokines. Science 23: 1035–1037

    Article  Google Scholar 

  • Yasuda N, Greer MA, Azizawa T (1982) Corticotropin-releasing factor. Endocr Rev 3: 123

    Article  PubMed  CAS  Google Scholar 

  • Zelazowski P, Dohler KD, Stepien H, Pawlikowski M (1989) Effect of growth hormone releasing hormone on human peripheral blood leukocyte chemotaxis and migration in normal subjects. Neuroendocrinology 50: 236

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Weigent, D.A., Blalock, J.E. (1994). Role of Neuropeptides in the Bidirectional Communication Between the Immune and Neuroendocrine Systems. In: Scharrer, B., Smith, E.M., Stefano, G.B. (eds) Neuropeptides and Immunoregulation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78480-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78480-4_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78482-8

  • Online ISBN: 978-3-642-78480-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics